Loading Events

Immunopeptidomics, Phosphoproteomics and Olink: state-of-the-art technologies to study Antigen discovery, Cell signalling and Biomarker discovery

Dr Pouya Faridi and Dr Terry Lim will briefly introduce three states of art technologies in the area of proteomics. They will explain how immunopeptidomics will enable of us to discover targets for immunotherapy of cancer, autoimmune and infectious diseases. In phosphoproteomics, we identify and characterize proteins containing phosphorylation as a posttranslational modification (PTM). This PTM dictates the protein function,  complex formations and cell signalling networks. Olinks is technology to identify and quantify extremely low abundant proteins in body fluids to discover biomarkers for cancer and inflammatory diseases.

This event will be held online via Zoom. Registrations essential.


Register for this event

Share This Story, Choose Your Platform!